Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 14.10

De Novo Posttransplant Solid Malignancy, 1999 to 2008

Heart Recipients

Malignancies by Type Year of Transplant
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008
Total # of Post-Tx Malignancies 515 495 400 311 249 186 193 125 51 6
Squamous/Basal Cell Carcinoma 294 267 244 178 150 103 117 86 29 4
Melanoma 22 18 17 7 14 9 4 3 2 -
Kaposi Sarcoma 1 - 1 - - - - 2 2 -
Central Nervous System 5 4 - - - - 1 1 - -
Genito-Urinary (1) 72 72 45 38 33 32 28 14 6 -
Gastro-Intestinal (2) 22 28 15 15 16 4 6 7 2 -
Primary Hepatic Tumor 2 3 2 - - - - - - -
Metastatic Hepatic Tumor 7 4 2 7 5 2 1 - - -
Larynx/Bronchi/Lung 63 46 41 35 15 20 16 3 2 1
Breast/Thyroid 10 10 15 6 8 5 5 4 5 -
Leukemia 2 1 - 5 - 2 1 - - -
Sarcoma (3) - 4 - 4 - - - - - -
Other 13 33 16 15 6 8 14 3 2 1
Unknown 2 5 2 1 2 1 - 2 1 -
Squamous/Basal Cell Carcinoma 57.1% 53.9% 61.0% 57.2% 60.2% 55.4% 60.6% 68.8% 56.9% 66.7%
Melanoma 4.3% 3.6% 4.3% 2.3% 5.6% 4.8% 2.1% 2.4% 3.9% -
Kaposi Sarcoma 0.2% - 0.3% - - - - 1.6% 3.9% -
Central Nervous System 1.0% 0.8% - - - - 0.5% 0.8% - -
Genito-Urinary (1) 14.0% 14.5% 11.3% 12.2% 13.3% 17.2% 14.5% 11.2% 11.8% -
Gastro-Intestinal (2) 4.3% 5.7% 3.8% 4.8% 6.4% 2.2% 3.1% 5.6% 3.9% -
Primary Hepatic Tumor 0.4% 0.6% 0.5% - - - - - - -
Metastatic Hepatic Tumor 1.4% 0.8% 0.5% 2.3% 2.0% 1.1% 0.5% - - -
Larynx/Bronchi/Lung 12.2% 9.3% 10.3% 11.3% 6.0% 10.8% 8.3% 2.4% 3.9% 16.7%
Breast/Thyroid 1.9% 2.0% 3.8% 1.9% 3.2% 2.7% 2.6% 3.2% 9.8% -
Leukemia 0.4% 0.2% - 1.6% - 1.1% 0.5% - - -
Sarcoma (3) - 0.8% - 1.3% - - - - - -
Other 2.5% 6.7% 4.0% 4.8% 2.4% 4.3% 7.3% 2.4% 3.9% 16.7%
Unknown 0.4% 1.0% 0.5% 0.3% 0.8% 0.5% - 1.6% 2.0% -
Total # of Patients 315 288 245 200 162 130 125 88 43 6


Source: OPTN/SRTR Data as of May 4, 2009.

(-) = None in category.

(1) Genito-Urinary: kidney, bladder, uterine cervix, uterine body, ovarian, vulva, testicular, prostate.

(2) Gastro-Intestinal: tongue, throat, esophagus, stomach, small intestine, colo-rectal, liver and biliary tract, pancreas.

(3) Sarcoma: fibrosarcoma, osteosarcoma, etc.

Recipient malignancy statistics are based on voluntary reporting to the OPTN.



PDF FormatRequires Adobe Acrobat Reader